Healthtech Startups

ExMedio provides an IT platform called Hipokura that enables physicians across specialties to share clinical knowledge, seek specialist consultations, and discuss cases to improve diagnostic and treatment quality. The platform serves doctors in Japan with over 70,000 registered physicians and includes specialized consultation features for dermatology, ophthalmology, cardiology, pulmonology, and rare diseases.

1 investor

Company positioned around injury care technology, with details pending a forthcoming website launch.

1 investor

Exogenus develops therapeutic exosomes derived from umbilical cord blood cells to treat autoimmune diseases through immune system rebalancing. The company targets multiple autoimmune disease indications where existing pharmaceutical treatments carry significant side effects.

1 investor

Exosomm is a biotechnology company that extracts and standardizes bioactive milk exosomes into commercial ingredients for advanced nutrition and supplement brands. The company licenses these bioactive compounds as a differentiated platform for premium health and wellness products.

1 investor

Expect Fitness runs a prenatal, postpartum and pelvic floor workout app with OB/GYN-approved streaming programs.

1 investor

Expedition Therapeutics is a drug development company focused on advancing therapeutic programs in areas such as CAR-T immunotherapy and oncology. The company serves patients and healthcare systems seeking novel treatment options.

1 investor

Experic is a CDMO (Contract Development and Manufacturing Organization) specializing in inhalation pharmaceutical product development, formulation engineering, and clinical manufacturing services. The company provides process development, analytical testing, technology transfer, and scale-up support for inhalation drugs and encapsulated solid dose pharmaceuticals.

1 investor

Experity develops software and AI-driven operational technology for on-demand and urgent care healthcare providers, supporting clinical operations, electronic medical records, and patient experience. It serves urgent care clinics and on-demand healthcare operators, positioning itself as an operating system for the sector.

1 investor

EXPIN develops AI-driven tools for clinicians to analyze exposome data—the lifetime accumulation of environmental, chemical, and lifestyle exposures—to enable precision medicine for chronic disease prevention and treatment. The company serves healthcare providers and patients seeking to understand how non-genetic factors drive disease at the molecular level.

1 investor

ExpiWell provides ecological momentary assessment (EMA) and experience sampling (ESM) software used by researchers to capture real-time data on participants' daily experiences, emotions, and behaviors. The platform enables peer-reviewed research across psychology, medicine, organizational behavior, and ESM methodology.

1 investor

ExploraMed is a medical device incubator that develops new med tech companies and products from early-stage concept through development. Its portfolio includes ventures such as Revelle Aesthetics, an aesthetics medical device company acquired by Tiger Aesthetics in 2024.

1 investor

Exposome researches how environmental factors affect human health and develops products through its formulations and application lab, supported by its own manufacturing facility. The company operates in the health and wellness space with in-house product development and production.

1 investor

Express Healthcare is an Indian news and media publication covering the healthcare industry, including hospitals, medical devices, pharma, and health startups. It publishes news, interviews, and analysis for healthcare professionals and industry stakeholders in India.

1 investor

EXTEDO develops regulatory information management (RIM) software and provides expert services for life sciences organizations to manage regulated documents, data and submission processes in compliance with global standards. It serves large pharmaceutical companies as well as small and mid-sized businesses and contract research organizations (CROs).

1 investor

Extendicare provides senior care services in Canada, including long-term care homes and related programs for the elderly. The company operates in the healthcare and senior living sector.

1 investor

Exubrion Therapeutics develops veterinary therapies using conversion electron therapy from Tin-117m to treat pain and inflammation in companion animals. Its initial product, Synovetin OA, is a minimally invasive intra-articular injection for canine elbow osteoarthritis, marketed to veterinarians and pet owners.

1 investor

Exxat provides a platform for managing clinical and experiential education, including curriculum, fieldwork assessments, competency-based education, credentialing, placement coordination, and accreditation. It serves academic institutions across health, allied, and behavioral sciences such as nursing, physical therapy, social work, counseling, and physician assistant programs, using AI-powered insights on student, site, and scheduling data.</parameter> <parameter name="founders">[]

1 investor

Eaglet Eye Medical (Aibo Medical) is a China-based manufacturer of ophthalmic medical devices covering eye surgery treatment, myopia control, and vision care. Its core products include intraocular lenses, orthokeratology lenses, and contact lenses, serving eye surgery, refractive error correction, and vision consumer needs.

1 investor

EyeBuddy develops AI tools for early detection of eye diseases that work alongside clinicians in hospitals and eye care facilities. The company serves ophthalmologists and healthcare providers in Canada, South Asia, and the UK, with a focus on making eye care accessible to underserved populations.

1 investor

EyeCheck develops vision screening tools to identify refractive errors and expand access to eye care for underserved populations globally.

1 investor

CHV is a venture capital firm that invests in medical technology companies developing therapeutic devices, diagnostic tools, and digital health solutions to improve patient outcomes.

1 investor

EyeD Pharma develops pharmaceutical treatments focused on ophthalmology, particularly for glaucoma and related eye conditions. The company serves ophthalmologists and eye care professionals in treating patients with vision-related diseases.

1 investor

eyeknow.ai offers an AI computer-vision platform that connects to a facility's existing security cameras to detect safety risks such as falls, aggression, and self-harm attempts and alert staff in real time. It targets psychiatric facilities and other care settings to help protect vulnerable patients and document incidents automatically.

1 investor

Eyenuk provides autonomous AI-based eye exams performed at the point of care to detect eye conditions including diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous signs. Its technology holds regulatory clearances such as a Class IIb CE mark under EU MDR and maintains SOC 2 Type 2, HIPAA, and GDPR compliance.

1 investor